Skip to main content
Tech.euFundingExplorerBeta

Vulpes Investment Management

Investor profile

Venture capital

Vulpes Investment Management has backed 2 European tech companies across 3 funding rounds between 2021 and 2024, joining rounds totalling €25M. Most active in HRtech and Healthtech. Data as of Nov 2026.

Deals
3
distinct rounds
Companies
2
backed
Active span
2021–2024
4 yrs
Total round €
€25M
sum of rounds joined

Deals by year

distinct rounds / year
Vulpes Investment Management — deals by year — interactive chart.
Data table
Vulpes Investment Management — deals by year
20211
20221
20241

Top sectors

by deals
Vulpes Investment Management — top sectors — interactive chart.
Data table
Vulpes Investment Management — top sectors
HRtech2
Healthtech1

Stages

by deals
Vulpes Investment Management — stages — interactive chart.
Data table
Vulpes Investment Management — stages
Other2
Series A1

Countries

by deals
Vulpes Investment Management — countries — interactive chart.
Data table
Vulpes Investment Management — countries
UK3

Co-investment network

shared rounds
Co-investment network — interactive chart.
Vulpes Investment Management — 3 dealsVulpes Investment ManagementACF investors — 2 shared deals · click to openACF investorsSamaipata — 2 shared deals · click to openSamaipataStage 2 Capital — 2 shared deals · click to openStage 2 Capital2Invest — 1 shared deals · click to open2InvestEpidarex Capital — 1 shared deals · click to openEpidarex CapitalFuture Fund — 1 shared deals · click to openFuture FundSofinnova Partners — 1 shared deals · click to openSofinnova PartnersSOV Ventures — 1 shared deals · click to openSOV VenturesTriple Point Ventures — 1 shared deals · click to openTriple Point Ventures

Hover a node for shared-deal counts; click a co-investor to open its profile.

Best viewed on a larger screen.

Portfolio

top 30 by total round €
CompanyCountryRoundsTotal €
Leucid BioUK1€14M
VeremarkUK2€11M

Biggest deals

top 10 by amount
CompanyStageAmountDate
Leucid BioSeries A€14M2021-10
VeremarkOther€8.3M2022-07
VeremarkOther€2.8M2024-04
← Back to investors